Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay
This study has been completed.
Study NCT00065273 Information provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First Received: July 21, 2003 Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mental Retardation
Developmental Delay Disorder
Additional conditions recognized in this trial
Developmental Disabilities
More general conditions related to this trial
Mental Disorders
Mental Disorders Diagnosed in Childhood
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
risperidone
clozapine
olanzapine
Additional drug interventions recognized in this trial
Antipsychotic Agents
More general drug interventions related to this trial
Antiemetics
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
GABA Agents
GABA Antagonists
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Serotonin Uptake Inhibitors
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Back to top of Main Content
